Exec-Edge – Page 2 – ExecEdge

Nanox To Deploy 300 Nanox.ARC Systems in The U.S. Over 3 Years

Nanox To Deploy 300 Nanox.ARC Systems in The U.S. Over 3 Years

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started two new U.S. collaborations to position its digital tomosynthesis system Nanox.ARC across the country. The first partnership is with Howard Technology Solutions to utilize 300 Nanox.ARC over a period...

Study Supports GlucoTrack’s Blood Glucose Monitoring Implant

Study Supports GlucoTrack’s Blood Glucose Monitoring Implant

By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said a peer-reviewed study published in the Institute of Electrical and Electronics Engineers Sensors Journal supported the feasibility of long-life implantable continuous glucose monitors like the devices the company develops. The article came...

Nanox Continues Expanding Nanox.ARC in U.S. & Israel

Nanox Continues Expanding Nanox.ARC in U.S. & Israel

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) announced it signed two new partnerships to continue deploying its digital tomosynthesis system Nanox.ARC both nationally and globally. The first collaboration is with Digital X-Ray Imaging Inc. to market, install and support...

Callio Therapeutics Presents Dual-Payload Antibody-Drug Conjugate

Callio Therapeutics Presents Dual-Payload Antibody-Drug Conjugate

By Daniella Parra Callio Therapeutics presented preclinical data at AACR that supports the first dual-payload antibody drug conjugate in Phase 1 for HER2-expressing cancers. While approved ADC drugs like Enhertu work initially, treatment resistance builds over time because of its...

Input your search keywords and press Enter.